Meet our CEO, Jodi Barrientos, at the J.P. Morgan Healthcare Conference, 2026.
We are redefining scientific possibility with our algorithm-driven technology that produces pristine MiroSynth™ DNA molecules, enabling our partners to deliver a new generation of transformative solutions for the health of people and planet.
Reach out to schedule a meeting: dna@ribbonbio.com
